2016 05 Mar
Over the past 25 years, gadolinium-based contrast agents (GBCA) have been recognised to have exceptional safety profiles with minimal side effects, as three researchers showed in their presentations at the European Congress of Radiology (ECR 2016) in Vienna. Dr. Richard Semelka of the Department of Radiology, University of North Carolina at Chapel... Read more
JOIN OUR MANAGEMENT COMMUNITY
Point-of-Care Ultrasound Takes to the Skies
EHAAT crew members and the SonoSite team with the new helicopterSonoSite... Read more
Sphere Medical Proxima™ Bedside Blood Gas Monitoring System Compatible with Philips IntelliVue
As a patient dedicated system, Proxima is always connected to the patient... Read more
UPMC, considers opportunities to join Moscow International Medical Cluster
UPMC, world-renowned health care provider from USA, arrived on official... Read more
Philips Speeds Up Research and Biomarker Discovery with Major Upgrade
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health techno... Read more
Clinical Trials Demonstrate Benefits of iFR Compared to FFR
The DEFINE FLAIR and iFR Swedeheart studies establish that iFR offers a... Read more
Catherine Estrampes Appointed President & CEO of GE Healthcare Europe
Catherine Estrampes has been announced as President & CEO for GE Healthcare... Read more
EOS imaging Appoints Mike Lobinsky to Newly Created Position of President, North America
Proven executive experienced in orthopedics and medical imaging will lead... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
Primex Pharmaceuticals Appoints Jostein Davidsen and Angelo Colombo as Board Members
Swiss pharmaceutical group Primex Pharmaceuticals AG announces new board... Read more
New President of Sectra’s Secure Communications Business Area
Simo Pykälistö, currently CFO and Executive Vice President of Sectra AB... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY